Valerio Therapeutics targets Aug. 21 signing for Etherna deal talks

Reuters2026/08/17 06:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Valerio Therapeutics is advancing plans to buy 100% of Etherna Immunotherapies, following a binding offer based on a EUR 30 million enterprise value.
The parties extended talks to complete definitive agreements, targeting signing by Aug. 21, 2026.
Foreign direct investment clearance required for the deal has been obtained.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valerio Therapeutics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260816266987) on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Valerio Therapeutics targets Aug. 21 signing for Etherna deal talks

You may also like

Crypto prices